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Abstract
Despite the advancements in pharmacological and non-pharmacological management of atrial
fibrillation (AF) observed during last decades, available treatment modalities and predictors of
their success are still far from optimal. Understanding of pathophysiological mechanisms
underlying AF and assessment of atrial electrophysiological properties using easily available
non-invasive diagnostic tools such as surface ECG are essential for further improvement of
patient-tailored treatment strategies. P-wave duration is generally accepted as the most reliable
non-invasive marker of atrial conduction and its prolongation has been associated with his-
tory of AF. However, patients with paroxysmal AF without structural heart disease may not
have any impressive P-wave prolongation thus suggesting that the global conduction slowing is
not an obligatory requirement for development of AF. In these settings, the morphology of
P-wave becomes an important source of information concerning propagation of atrial activa-
tion. One of the most common morphologies, i.e. biphasic configuration of P-waves in right
precordial leads has been considered a marker of left atrial enlargement but, seen in patients
with structurally normal hearts, appears to be linked to an interatrial conduction defect.
Recent advances in endocardial mapping technologies have linked certain P-wave morphologies
with interatrial conduction patterns that may have clinical implications for invasive treatment
of AF patients. The value of P-wave morphology extends beyond cardiac arrhythmias asso-
ciated with atrial conduction delay and can be used for prediction of clinical outcome of wide
range of cardiovascular disorders such as survival after myocardial infarction or the risk of
stroke. (Cardiol J 2008; 15: 402–407)
Key words: P-wave, electrocardiography, interatrial conduction, atrial fibrillation
Introduction
Atrial fibrillation (AF) remains the most com-
mon cardiac arrhythmia demanding treatment, and
the number of patients affected worldwide is incre-
asing along with the ageing of the population in the
industrial world. Despite the advances in pharmaco-
logical and non-pharmacological management of AF,
observed during recent decades, we are still far from
being satisfied with the available treatment modali-
ties and predictors of their success. Understanding
of pathophysiological mechanisms underlying AF and
assessment of atrial electrophysiological properties
using easily available non-invasive diagnostic tools
such as surface ECG are essential for further impro-
vement of patient-tailored treatment strategies.
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Conduction velocity in
atrial fibrillation genesis
The presence of triggers, shortened refracto-
riness and delayed conduction are important pre-
requisites for re-entry underlying AF [1]. The
likelihood that a trigger can initiate a arrhythmia
that could sustain itself requires an arrhythmic sub-
strate in the atria and depends on the length of the
re-entry wavelet defined as a product of the local
effective refractory period and the conduction veloci-
ty. Slowing conduction, resulting in shorter wavelength,
increases the number of wavelets that could coexist in
the given atrial dimensions thus increasing the likeli-
hood that AF would sustain itself. This mechanism
underlying AF has been confirmed in animal experi-
ments and clinical studies reviewed recently [2].
P-wave duration is generally accepted as the
most reliable non-invasive marker of atrial conduc-
tion and its prolongation has been associated with
history of AF [3], the development of the arrhyth-
mia after bypass surgery [4] and deterioration of
paroxysmal AF into the permanent form of the arr-
hythmia [5]. In 1985, Bayes de Luna et al. [6] de-
scribed an advanced interatrial block with retrogra-
de activation of the left atrium associated with hi-
stories of atrial tachyarrhythmias, that was later
confirmed by others [5, 7]. This kind of interatrial
block is seen on the surface ECG as a wide (> 120 ms)
and biphasic P-wave in the inferior leads (Fig. 1,
Type 3) [8]. While the prevalence of this advanced
block is relatively low, the partial interatrial block
defined as a P-wave longer than 120 ms with possi-
ble notched morphology is a much more common
finding and in a recent report was documented in
about 40% of hospitalized patients [9].
Atrial fibrosis, either age-related [10] or caused
by coexisting conditions such as heart failure or hy-
pertension [2], may result in a slowing of atrial con-
duction observed as a prolongation of P-wave on the
surface ECG. However, the P-wave prolongation per
se may be regarded only as a marker of general slo-
wing of atrial conduction secondary to extended
structural abnormalities of atrial walls and interatrial
pathways. In reality, patients with paroxysmal AF
without structural heart disease may not have any
impressive P-wave prolongation thus suggesting that
global conduction slowing is not an obligatory requ-
irement for the development of AF [11–13].
P-wave morphology
In the absence of significant P-wave prolonga-
tion in patients without structural heart disease, the
Figure 1. Common orthogonal P-wave morphologies. Type 1: Upright P-waves in all orthogonal leads — common in
healthy subjects below 50 years of age; Type 2: Upright P-waves in leads X and Y and biphasic in lead Z — common
in patients with paroxysmal atrial fibrillation, left atrial enlargement but may also be seen in healthy older than 50;
Type 3: Upright in X but biphasic in leads Y and Z — advanced interatrial block, often associated with prolongation of
P-wave >120 ms. This P-wave morphology is uncommon in healthy subjects.
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morphology of P-wave becomes an important sour-
ce of information concerning propagation of atrial
activation.
The interest in P-wave morphology in this setting
dates back to the mid 1960s when Morris et al. [14]
introduced the concept of a P-wave negative ter-
minal force (PTF) seen as a pronounced negative
deflection in the terminal portion of the P-wave in
the right precordial leads in patients with known
mitral or aortic valve disease (Fig. 2) that has long
been regarded as a marker of left atrial enlargement.
Shortly thereafter, Robitaile et al. [15] suggested
that abnormal PTF is associated with the presence of
paroxysmal AF. Ten years later, Josephson et al.  [16]
suggested that biphasic P-waves in the right pre-
cordial leads may represent an interatrial conduc-
tion defect, not necessarily linked to left atrial en-
largement.
The variability of the normal P-wave morpho-
logy has been appreciated. The P-wave vector in
the frontal plane may vary from –50 to +60 degre-
es, reflecting right-to-left propagation of the wave
front originating in the sinus node located at the
junction of the superior vena cava and right atrium.
In the precordial leads, P-waves are usually positi-
ve with only exception: lead V1. In this lead,
P-waves may be upright, biphasic (+/–) or negati-
ve [17]. Observations of abnormal PTF in V1 in ap-
parently healthy men 40–60 years old have also
been reported [18]. Our group has studied P-wave
morphology in 120 healthy men and women aged
20 to 80 years and observed that although biphasic
P-waves in the Z-lead are observed in healthy sub-
jects, this particular morphological pattern was ob-
served predominantly in subjects over 50 years of
age, in whom any other P-wave morphologies were
unusual [19] (Fig. 3). However, even in this heal-
thy cohort several atypical P-wave morphologies.
What makes P-waves appear to be biphasic or
monophasic in right precordial leads? Using elec-
tro-anatomical mapping of the left atrium during
sinus rhythm, our group proposed an explanation
of the origin of P-wave morphology in subjects wi-
thout structural heart disease [20]. Upright P-wave
in the right precordial leads appears to be associa-
ted with conduction, not only via Bachmann’s bun-
dle but also via other interatrial connections in the
vicinity of the right pulmonary veins on the back
side of the heart, thus resulting in posterior-to-an-
terior propagation of sinus beat in both right and left
atria (Fig. 4A). Several endocardial mapping studies
have demonstrated that conduction via these poste-
rior connections, not via Bachmann’s bundle, may
dominate during sinus rhythm [21, 22]. Biphasic
P-waves in these leads, on the other hand, are as-
sociated with conduction via Bachmann’s bundle
only resulting in the anterior-to-posterior direction
of left atrial activation, i.e. the terminal part of the
P-wave (Fig. 4B). It is therefore plausible to suggest
that posterior interatrial connections, known to be
generally thinner and less developed compared to the
Bachmann’s bundle [23, 24], are therefore more af-
fected by ageing and leave only Bachmann’s bundle
as a major interatrial route in middle-aged and se-
nior patients, leading to biphasic P-waves in the ri-
ght precordial leads in the surface ECG.
One should bear in mind, however, that these
considerations are only applicable for subjects wi-
thout considerable left atrial enlargement. Incre-
ased size of the atrial chamber itself may affect the
vector of propagation of sinus beat resulting in the
Figure 2. P-wave terminal force defined as the product
of the duration (D) and amplitude (A) of the terminal
phase of the P-wave in lead V1; PTF > 0.04 mV × ms
has been found to be specific but less sensitive ECG
marker of left atrial enlargement [25].
Figure 3. Distribution of common P-wave morphologies
in healthy subjects. Younger subjects (20–49 years old)
have nearly equal representation of Type 1 and Type 2
P-waves while middle-aged and seniors (50–80 years old)
have predominantly Type 2 morphology.
405
Pyotr G. Platonov, Atrial conduction and atrial fibrillation
www.cardiologyjournal.org
abnormal PTF in lead V1 as shown recently in
a study using cardiac magnetic resonance imaging [25].
The resulting P-wave morphology is therefore
a complex interplay of geometrical and electrophy-
siological considerations, both affecting the way the
sinus beat travels across the atria.
Local disturbance of interatrial
conduction and atrial fibrillation
Apart from the rare finding of advanced intera-
trial block with retrograde left atrial activation as-
sociated with atrial arrhythmias and AF in particu-
lar, the morphology of P-waves has mostly been
neglected in the context of this arrhythmia. In the
limited material of patients with lone AF, we repor-
ted the presence of significant differences in P-wave
morphology between patients with lone paroxysmal
AF and healthy subjects not associated with any
substantial P-wave prolongation [11], thus sugge-
sting that the local rather than global slowing of
interatrial conduction may be related to AF mecha-
nisms in this patient cohort. The differences were
mostly confined to the orthogonal lead Z, correspon-
ding to the V1–V2 chest leads where we observed
biphasic P-waves in the majority of AF patients. In
a recent study, similar findings were obtained using
the same unfiltered P-wave signal-averaged ECG
technique in a cohort of patients with hypertrophic
obstructive cardiomyopathy known for their higher
risk of developing AF [26].
However, it is important to acknowledge that
solid data linking histological substrates to deterio-
rated atrial conduction and higher propensity of AF
are still lacking. Diffuse structural abnormalities
such as vacuolar degeneration, inflammatory changes
and fibrosis have been reported in patients with lone
AF [27]. Critically located lesions have been shown
by Becker et al. [10], who described the presence of
an extensive fibro-fatty replacement of Bachmann’s
bundle in patients with a history of AF. Our group has
not been able to document differences either in the
structure or location of interatrial connections asso-
ciated with a history of AF in the largest anatomical
study to date on 84 human hearts [28].
Clinical implications of P-wave morphology
The diagnostic potential of P-wave morpholo-
gy for the delineation of interatrial conduction and
Figure 4. Schematic representation of the genesis of biphasic P-waves in leads V1 and Z in patients without structural
heart disease. Interatrial conduction over the posterior interatrial connections result in the posterior-to-anterior
propagation of exitation in the left atrium and positive or isoelectric P-waves in V1/lead Z (Type 1, panel A). Interatrial
conduction over Bachmann’s bundle only without contribution from posterior interatrial connections result in the
anterior-to-posterior activation of the left atrium and biphasic P-wave in V1/lead Z [26].
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identification of interatrial routes participating in
the propagation of sinus beats indicates its possi-
ble use for guiding the placement of the atrial lead
for optimal atrial resynchronization. Several studies
have addressed the effect of atrial septal pacing for
the prevention of paroxysmal AF by placing the
atrial lead in the vicinity of Bachmann’s bundle[29],
the postero-inferior interatrial connections [30–32]
or both [33]. While some studies have demonstra-
ted the clinical benefit of atrial septal pacing
[29, 31, 32], the largest one, by Padeletti et al. [33],
did not show any decrease in AF burden. The se-
lection of patients that would benefit from this tre-
atment is therefore still poorly defined, and the
selection of a pacing technique is not individually
tailored. However, these trials demonstrated that
septal electrode placement is safe and it is likely
that in patients with indication for atrial pacing the
septal positioning of the electrode guided by P-wave
morphology would improve the resynchronisation
effect and possibly improve rhythm control in pa-
tients with paroxysmal AF.
The clinical implications of P-wave morpholo-
gy analysis extend beyond its use as a marker of
left atrial enlargement and show it to be more than
yet another characteristic of interatrial conduction
during sinus rhythm. In a registry-based analysis
of discharge ECGs of 641 patients who survived the
acute phase of myocardial infarction, abnormal PTF,
observed in 11% of the patients, was associated with
a nearly two-fold increase in 5-year mortality [34].
In other, smaller studies, abnormal PTF was found
to be a predictor of poor prognosis during acute
phase of myocardial infarction [35, 36] and at 4-year
follow-up after myocardial infarction [37], and the
risk of stroke [38]. These data demonstrate that
regardless of the mechanisms underlying the ge-
nesis of the P-wave morphology, its value extends
beyond cardiac arrhythmias associated with atrial
conduction delay and can be used for the prediction
of the clinical outcome of a wide range of cardiova-
scular disorders.
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